| 1 |
31274831 | Effects of the Poly(ADP-Ribose) Polymerase Inhibitor Olaparib in Cerulein-Induced Pancreatitis. | 2020 May |
1 |
| 2 |
31071432 | The PARP inhibitor olaparib exerts beneficial effects in mice subjected to cecal ligature and puncture and in cells subjected to oxidative stress without impairing DNA integrity: A potential opportunity for repurposing a clinically used oncological drug for the experimental therapy of sepsis. | 2019 Jul |
1 |
| 3 |
28657402 | In vitro evaluation of the inhibition and induction potential of olaparib, a potent poly(ADP-ribose) polymerase inhibitor, on cytochrome P450. | 2018 Jun |
3 |
| 4 |
29064327 | The expression of APE1 in triple-negative breast cancer and its effect on drug sensitivity of olaparib. | 2017 Oct |
4 |
| 5 |
22524618 | The combination of olaparib and camptothecin for effective radiosensitization. | 2012 Apr 23 |
2 |